Results 211 to 220 of about 16,696 (258)

The use of a neuromuscular blocking agent could significantly decrease mortality in moderate-to-severe ARDS patients: is moderate ARDS the best indication for neuromuscular blocking agents. [PDF]

Crit Care, 2020
Honore PM, Mugisha A, Kugener L, Redant S, Attou R, Gallerani A, De Bels D.   +6 more
europepmc   +1 more source

Sugammadex as a reversal agent for neuromuscular block: an evidence-based review

, 2013
Heidrun Fink, Stefan J. Schaller
openalex   +2 more sources

Current Use of Neuromuscular Blocking Agents in Intensive Care Units. [PDF]

Turk J Anaesthesiol Reanim, 2019
Tezcan B, Turan S, Özgök A.
europepmc   +1 more source

Neuromuscular blocking agents for acute respiratory distress syndrome. [PDF]

J Crit Care, 2019
Torbic H, Duggal A.
europepmc   +1 more source

Neuromuscular blocking agents for acute respiratory distress syndrome: how did we get conflicting results? [PDF]

Crit Care, 2019
Torbic H, Krishnan S, Duggal A.
europepmc   +1 more source

Role of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials. [PDF]

Front Pharmacol, 2019
Wei XB, Wang ZH, Liao XL, Guo WX, Qin TH, Wang SH.   +5 more
europepmc   +1 more source

To study the adequacy of surgical muscle relaxation in paediatric patients scheduled for elective groin surgeries under general anesthesia using sevoflurane without using neuromuscular blocking agents

, 2016
Muhammad Ahmad Khan, Motsim Sheraz, Sayed Sajjad Raza Kazmi   +2 more
openalex   +2 more sources

Acyclic Cucurbit[n]uril-Type Containers as Receptors for Neuromuscular Blocking Agents: Structure-Binding Affinity Relationships. [PDF]

Croat Chem Acta, 2019
Shaya D, Isaacs L.
europepmc   +1 more source

Use of neuromuscular blocking agents in acute respiratory distress syndrome. [PDF]

Proc (Bayl Univ Med Cent), 2018
Tsai-Nguyen G, Modrykamien AM.
europepmc   +1 more source